TIVIC HEALTH SYSTEMS INC

NASDAQ: TIVC (Tivic Health Systems, Inc.)

Last update: 4 days ago, 3:49PM

4.27

-0.05 (-1.16%)

Previous Close 4.32
Open 4.16
Volume 26,368
Avg. Volume (3M) 1,292,187
Market Cap 2,647,985
Price / Sales 1.64
Price / Book 0.980
52 Weeks Range
2.43 (-43%) — 16.08 (276%)
Operating Margin (TTM) -857.22%
Diluted EPS (TTM) -19.67
Quarterly Revenue Growth (YOY) -49.60%
Current Ratio (MRQ) 9.70
Operating Cash Flow (TTM) -5.72 M
Levered Free Cash Flow (TTM) -3.27 M
Return on Assets (TTM) -88.85%
Return on Equity (TTM) -184.96%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Bearish Mixed
Medical Devices (Global) Bearish Mixed
Stock Tivic Health Systems, Inc. - -

AIStockmoo Score

-1.0
Analyst Consensus -2.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators -2.5
Average -1.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TIVC 3 M - - 0.980
QDEL 2 B - - 0.800
IART 2 B - - 0.690
AHCO 1 B - 16.00 0.780
INMD 896 M - 6.54 1.56
OFIX 569 M - - 1.10

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body’s own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Sector Healthcare
Industry Medical Devices
Investment Style Small Value
% Held by Insiders 0.18%
% Held by Institutions 2.33%

No data within this time range.

No data within this time range.

Date Type Details
20 May 2025 Announcement Sidoti Events, LLC's Virtual May Micro-Cap Conference
15 May 2025 Announcement Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation
14 May 2025 Announcement Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission
13 May 2025 Announcement Tivic Expands VNS Intellectual Property Portfolio
09 May 2025 Announcement Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast
22 Apr 2025 Announcement Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates
10 Apr 2025 Announcement Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
21 Mar 2025 Announcement Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth
13 Mar 2025 Announcement Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast
06 Mar 2025 Announcement Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System
05 Mar 2025 Announcement Tivic Health Systems, Inc. Announces Reverse Stock Split
03 Mar 2025 Announcement Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve
24 Feb 2025 Announcement Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria